Breaking News Instant updates and real-time market news.

CLRB

Cellectar Biosciences

$1.60

-0.02 (-1.23%)

08:10
10/15/19
10/15
08:10
10/15/19
08:10

Cellectar Biosciences presents data on PLE molecules in tumors

Cellectar Biosciences announced Jarrod Longcor, chief business officer of Cellectar, presented a poster at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology, being held from October 15 - 17, 2019 in London, United Kingdom. The poster, entitled: "Phospholipid ether delivery vehicle shows specificity for a broad range of tumor cells and provides a novel and improved approach for targeted therapy," featured data demonstrating that phospholipid ether drug conjugates were capable of delivering small molecule cytotoxins selectively to tumor cells and were well tolerated in animal models. In the data presented, all animals exposed to a single infusion of the payload alone died, while all animals receiving multiple doses with the PDCs survived with no adverse effects observed at all dose levels tested. Additionally, PDCs showed rapid uptake and release of 20% to 40% of the conjugate and payload in a wide range of tumor cells. The PDCs also demonstrated potent activity against the tumor cells with inhibitory concentrations in the low nanomolar range.

CLRB Cellectar Biosciences
$1.60

-0.02 (-1.23%)

05/02/19
HCWC
05/02/19
INITIATION
Target $4
HCWC
Buy
Cellectar Biosciences initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Cellectar Biosciences with a Buy rating and $4 price target.
07/29/19
BRKL
07/29/19
INITIATION
Target $6
BRKL
Buy
Cellectar Biosciences initiated with a Buy at Brookline
Brookline Capital Markets analyst Kumaraguru Raja initiated Cellectar Biosciences with a Buy and $6 price target.
09/13/19
ROTH
09/13/19
INITIATION
Target $11
ROTH
Buy
Cellectar Biosciences initiated with a Buy at Roth Capital
Roth Capital analyst Jerry Isaacson initiated Cellectar Biosciences with a Buy rating and $11 price target, saying he expects numerous efficacy readouts before the end of 2019, in R/R multiple myeloma and R/R diffuse large B-cell lymphoma. Cellectar has successfully brought CLR 131 through clinical trials targeting hematological malignancies and has a clear pathway to approval for the treatment of late-stage multiple myeloma, Isaacson tells investors in a research note.
10/01/19
ROTH
10/01/19
NO CHANGE
Target $11
ROTH
Buy
Roth Capital reiterates Buy rating on Cellectar after ESMO meeting
Roth Capital analyst Jerry Isaacson reiterated his Buy rating and $11 price target on Cellectar Biosciences after the company presented updated data at the European Society for Medical Oncology conference. The analyst notes that the new data detail responses from six patients with DLBCL, indicating an overall clinical benefit rate of 50%, a 33% overall response rate and a CR in one patient. CLR 131 is a targeted radiotherapeutic for which Cellectar is seeking an initial indication for relapsed and remitting hematological malignancies. The company recently announced Orphan Designation for CLR 131 in MM in Europe, he adds.

TODAY'S FREE FLY STORIES

INVE

Identiv

$4.92

-0.08 (-1.60%)

12:08
11/13/19
11/13
12:08
11/13/19
12:08
Hot Stocks
Identiv partners with GTSC to address 'evolving threats' to U.S. agencies »

Identiv announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$290.51

-1.5 (-0.51%)

, DIS

Disney

$137.18

-1.38 (-1.00%)

12:08
11/13/19
11/13
12:08
11/13/19
12:08
Hot Stocks
Breaking Hot Stocks news story on Netflix, Disney »

Netflix down 1% to…

NFLX

Netflix

$290.51

-1.5 (-0.51%)

DIS

Disney

$137.18

-1.38 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

12:05
11/13/19
11/13
12:05
11/13/19
12:05
General news
Powell didn't fully answer why analysts have low rates even as government spending increases »

Powell didn't fully…

DIS

Disney

$137.19

-1.37 (-0.99%)

12:04
11/13/19
11/13
12:04
11/13/19
12:04
Hot Stocks
Disney turns positive after announcing 10M streaming sign-ups »

The stock is up 15c to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$179.30

-0.49 (-0.27%)

, MA

MasterCard

$278.23

1.12 (0.40%)

12:04
11/13/19
11/13
12:04
11/13/19
12:04
Periodicals
FTC probing Visa, MasterCard over debit card transactions, Bloomberg reports »

Visa (V) and MasterCard…

V

Visa

$179.30

-0.49 (-0.27%)

MA

MasterCard

$278.23

1.12 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DIS

Disney

$137.23

-1.33 (-0.96%)

12:03
11/13/19
11/13
12:03
11/13/19
12:03
Hot Stocks
Breaking Hot Stocks news story on Disney »

Disney says streaming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$47.45

5.44 (12.95%)

12:00
11/13/19
11/13
12:00
11/13/19
12:00
Hot Stocks
Energizer rises 13.2% »

Energizer is up 13.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 21

    Nov

SPB

Spectrum Brands

$60.10

8.91 (17.41%)

12:00
11/13/19
11/13
12:00
11/13/19
12:00
Hot Stocks
Spectrum Brands rises 17.0% »

Spectrum Brands is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LN

Line Corp.

$49.79

9.12 (22.42%)

12:00
11/13/19
11/13
12:00
11/13/19
12:00
Hot Stocks
Line Corp. rises 21.9% »

Line Corp. is up 21.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRX

Catalyst Pharmaceuticals

$4.40

-0.51 (-10.39%)

11:57
11/13/19
11/13
11:57
11/13/19
11:57
Recommendations
Catalyst Pharmaceuticals analyst commentary  »

Catalyst Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CTAS

Cintas

$249.50

-9.4 (-3.63%)

11:56
11/13/19
11/13
11:56
11/13/19
11:56
Recommendations
Cintas analyst commentary  »

Baird says Cintas short…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$193.14

-1.33 (-0.68%)

11:55
11/13/19
11/13
11:55
11/13/19
11:55
Periodicals
China-owned TikTok is challenging Facebook for advertisers, Adweek says »

Adweek's platforms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$122.85

-1.25 (-1.01%)

11:50
11/13/19
11/13
11:50
11/13/19
11:50
Options
Put sale in Tiffanys opens 100 strike block in Feb »

Put sale in Tiffanys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
11/13/19
11/13
11:50
11/13/19
11:50
General news
Powell on the next downturn: generally the Fed has cut 500 bps in recessions »

Powell on the next…

TCDA

Tricida

$37.50

-2.21 (-5.57%)

11:49
11/13/19
11/13
11:49
11/13/19
11:49
Conference/Events
Tricida participates in a conference call with JPMorgan »

SMid Biotech Analyst Fye…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ADPT

Adaptive Biotechnologies

$26.60

-1.75 (-6.17%)

11:47
11/13/19
11/13
11:47
11/13/19
11:47
Recommendations
Adaptive Biotechnologies analyst commentary  »

Adaptive Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

KNSA

Kiniksa

$6.62

-0.1 (-1.49%)

11:40
11/13/19
11/13
11:40
11/13/19
11:40
Conference/Events
Kiniksa participates in a conference call with JMP Securities »

JMP Securities hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

11:40
11/13/19
11/13
11:40
11/13/19
11:40
General news
Powell on max employment: the economy can operate at a much lower level of unemployment »

Powell on max employment:…

AAPL

Apple

$264.01

2.12 (0.81%)

, SJM

J.M. Smucker

$105.50

0.36 (0.34%)

11:36
11/13/19
11/13
11:36
11/13/19
11:36
On The Fly
Apple initiation, J.M. Smucker downgrade among today's top analyst calls »

Check out today's top…

AAPL

Apple

$264.01

2.12 (0.81%)

SJM

J.M. Smucker

$105.50

0.36 (0.34%)

TTWO

Take-Two

$119.53

0.53 (0.45%)

MOS

Mosaic

$20.05

-0.89 (-4.25%)

FCX

Freeport McMoRan

$10.93

-0.12 (-1.09%)

AA

Alcoa

$21.64

-0.545 (-2.46%)

ALB

Albemarle

$65.09

-0.19 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 19

    Nov

  • 21

    Nov

  • 22

    Nov

  • 12

    Dec

LYV

Live Nation

$64.81

0.055 (0.08%)

11:35
11/13/19
11/13
11:35
11/13/19
11:35
Hot Stocks
Live Nation, Rakuten partner to offer new members rewards and ticket offers »

Rakuten and Live Nation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIP

TripAdvisor

$30.77

-0.93 (-2.93%)

11:35
11/13/19
11/13
11:35
11/13/19
11:35
Options
TripAdvisor put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 26

    Nov

V

Visa

$179.73

-0.06 (-0.03%)

, MA

MasterCard

$279.01

1.9 (0.69%)

11:33
11/13/19
11/13
11:33
11/13/19
11:33
Periodicals
FTC probing Visa, MasterCard over debit card transactions, Bloomberg reports »

The Federal Trade…

V

Visa

$179.73

-0.06 (-0.03%)

MA

MasterCard

$279.01

1.9 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

EXEL

Exelixis

$16.18

0.84 (5.48%)

11:25
11/13/19
11/13
11:25
11/13/19
11:25
Options
Exelixis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESRX

Express Scripts

$0.00

(0.00%)

11:25
11/13/19
11/13
11:25
11/13/19
11:25
Conference/Events
Detroit Economic Club to hold a luncheon meeting »

Tim Wentworth, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

11:20
11/13/19
11/13
11:20
11/13/19
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.